{
    "clinical_study": {
        "@rank": "20204", 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate alterations in the serotonergic system in cocaine\n      addicts and attempt to dissociate changes secondary to cocaine use from those associated\n      with premorbid characteristics."
        }, 
        "brief_title": "Alterations in Serotonergic Functions in Cocaine Addicts - 1", 
        "condition": "Cocaine-Related Disorders", 
        "condition_browse": {
            "mesh_term": "Cocaine-Related Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": "0", 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000312", 
            "org_study_id": "NIDA-09468-1", 
            "secondary_id": "R01-09468-1"
        }, 
        "intervention": {
            "intervention_name": "M-CPP", 
            "intervention_type": "Drug"
        }, 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Brooklyn", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "11209"
                }, 
                "name": "VA Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Alterations in Serotonergic Functions in Cocaine Addicts", 
        "overall_official": {
            "affiliation": "Department of Veterans Affairs", 
            "last_name": "Laure Buydens-Branchey, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "primary_outcome": [
            {
                "measure": "Side effects"
            }, 
            {
                "measure": "Neuroendocrine changes"
            }, 
            {
                "measure": "Psychological changes"
            }, 
            {
                "measure": "Craving"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000312"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "Department of Veterans Affairs", 
                "agency_class": "U.S. Fed"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2002"
    }, 
    "geocoordinates": {
        "VA Medical Center": "40.653 -73.959"
    }
}